Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens

Current inactivated vaccines against influenza A viruses (IAV) mainly induce immune responses against highly variable epitopes across strains and are mostly delivered parenterally, limiting the development of an effective mucosal immunity. In this study, we evaluated the potential of intranasal form...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Cynthia Calzas, Molida Mao, Mathilde Turpaud, Quentin Viboud, Joelle Mettier, Thomas Figueroa, Pierre Bessière, Antoine Mangin, Laura Sedano, Pierre-Louis Hervé, Romain Volmer, Mariette F. Ducatez, Steve Bourgault, Denis Archambault, Ronan Le Goffic, Christophe Chevalier
Format:	article
Langue:	EN
Publié:	Frontiers Media S.A. 2021
Sujets:	influenza A viruses highly pathogenic avian influenza virus mucosal vaccines adjuvants nanoparticles M2e/HA2 subunit vaccines Immunologic diseases. Allergy RC581-607
Accès en ligne:	https://doaj.org/article/ce5eeb8fd4fc4f3c89ecec190951fa7b
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens

Documents similaires